John T. Maxwell

Chief Financial Officer, Aquestive Therapeutics, Inc.

Companies

Wejo Group LtdBoard member Nov 19, 2021 to Nov 21, 2022¹
Wejo Group LtdChief financial officer Nov 19, 2021 to Nov 21, 2022¹
Aquestive Therapeutics, Inc.Chief financial officer Jul 24, 2018 to Aug 19, 2020²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Wejo Group Ltd477,350 shares³Nov 21, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 19, 2022Shares withheld for tax 74,456 shares at $0.84 of Wejo Group Ltd³
Jul 27, 2022Granted 36,757 shares at $1.36 of Wejo Group Ltd⁴
Jul 27, 2022Granted 36,757 shares at $1.36 of Wejo Group Ltd⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARWejo Group Ltd, Board member
2
SEC EDGARAquestive Therapeutics, Inc., Chief financial officer
3
SEC EDGARWejo Group Ltd shares after the filing of Nov 21, 2022
4
SEC EDGARForm 4 filed Jul 29, 2022